OPTIMIZING FEXUPRAZAN TREATMENT DURATION FOR ENDOSCOPIC SUBMUCOSAL DISSECTION–INDUCED ARTIFICIAL GASTRIC ULCERS: A MULTICENTER, RANDOMIZED, ACTIVE-CONTROLLED TRIAL (UEGW 2026) - Jul 15, 2026 - Abstract #MP0249; Pres time: Oct 18, 2026; 04:24 PM - 04:30 PM; Location: Hall 7 - Poster Stage 4; "Fexuprazan led to faster and more complete healing of ESD-induced gastric ulcers than esomeprazole, with a comparable safety profile, suggesting that effective healing can be achieved within approximately 6 weeks in most cases."
Clinical • Gastric Cancer • Peptic Ulcer • Solid Tumor
|
|
H.K. Hyun 1; J. Hwang 1; C.W. Huh 1
|